2/7 Psychiatric Genomics Consortium: Finding Actionable Variation
$68,597U01FY2020MHNIH
Massachusetts General Hospital, Boston MA
Investigators
Linked publications & trials
Paper 39040195Paper 38561342Paper 36711496Paper 36131047Paper 35513724Paper 35396579Paper 35361970Paper 34865855Paper 34140656Paper 33648717Paper 33495439Paper 32529491Paper 32492425Paper 32191043Paper 32066696Paper 32064741Paper 31835028Paper 31824658Paper 31768057Paper 31740837Paper 31628418Paper 31607513Paper 31558221Paper 31182215Paper 30610198Paper 30482948Paper 30478444Paper 30456828Paper 30424865Paper 30087453Paper 29292387Paper 28504703Paper 28494655Paper 28439101Paper 27869829
Abstract
ABSTRACT The Psychiatric Genomics Consortium aims to aggregate and analyze genetic data to advance our understanding of psychiatric disorders. The continued success of the PGC has seen the scale of the project increase as we attract more collaborators and expand to study a wider range of psychiatric disorders. With this growth we see the need for the appointment of a new position, the Data Intake Officer (DIO).
View original record on NIH RePORTER →